We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+0.32%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$282M
AUM Growth
+$5.08M
Cap. Flow
+$6.26M
Cap. Flow %
2.22%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
1
Closed

Top Buys

Rank Stock Value
1
RXDX
Ignyta, Inc.
RXDX
+$6.42M

Top Sells

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$162K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$120M 42.49%
8,643,739
-11,175
-0.1% -$162K
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$102M 36.35%
3,440,419
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
$49.3M 17.5%
4,763,602
+790,802
+20% +$6.42M
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.19M 2.91%
90,215
BGMS
5
Bio Green Med Solution Inc
BGMS
$5.05M
$2.11M 0.75%
8

Similar funds

Tang Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Tang Capital Management held 5 positions worth $282M, up 1.8% from $277M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 0%. Tang Capital Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tang Capital Management added most to Ignyta, Inc. in Q2 2017, an estimated $6.42M increase.
  • Tang Capital Management's biggest Q2 2017 reduction was Heron Therapeutics, cutting an estimated $162K.
  • Tang Capital Management's ten largest holdings make up 100% of its $282M portfolio in Q2 2017.
  • Tang Capital Management opened 0 new positions and closed 0 in Q2 2017.
  • Tang Capital Management's portfolio value rose 1.8% quarter-over-quarter to $282M.

Based on Tang Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.